| 419 | 9 | 203 |
| 下载次数 | 被引频次 | 阅读次数 |
本研究对早产儿视网膜病变的发生及筛查现状进行了介绍,阐述了早产儿视网膜病变的发病现状、危害、影响因素、筛查率、筛查方法及筛查不良反应等,梳理了国家层面相关的政策支持,分析了各地筛查网络的积极建设情况,为实现各机构协同合作、降低早产儿视网膜病变发生率、预防其发生提供建议。
Abstract：This paper described the current situation of the occurrence and screening of premature retinopathy. The harm,associated factors, screening rate, screening methods and adverse reactions were elaborated. The relevant national policy support was sorted out. This paper analysed the positive construction of screening network in China,so as to provide suggestions for implementing institutional collaboration, reducing incidence and preventing retinopathy of prematurity.
[1] Quinn JA, Munoz FM, Gonik B, et al. Preterm birth:case definition&guidelines for data collection, analysis, and presentation of immunisation safety data[J].Vaccine, 2016,34(49):6047-6056.
[2] Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens:preliminary report[J]. Am J Ophthalmol,1942,25:203-204.
[3] Ludwig CA, Chen TA, Hernandez-boussard T, et al.The epidemiology of retinopathy of prematurity in the United States[J]. OSLI Retina, 2017,48(7):553-562.
[4]周也群,陈超,陈露,等.中国大陆早产儿视网膜病变临床特点和眼底病变的多中心调查[J].中国循证儿科杂志, 2015,10(3):161-165.
[5]彭铎,鲁曦婷,李之喆,等.宫内生长发育迟缓和早产儿视网膜病变的关系研究[J].国际眼科杂志,2018(1):163-165.
[6] Hartnett ME. Retinopathy of prematurity:evolving treatment with anti-vascular endothelial growth factor[J].Am J Ophthalmol, 2020,218:208-213.
[7] Holmstrom GE, Kallen K, Hellstrom A, et al. Ophthalmologic outcome at 30 months’ corrected age of a prospective Swedish cohort of children born before 27 weeks of gestation:the extremely preterm infants in Sweden study[J]. JAMA Ophthalmol, 2014, 132(2):182-189.
[8]储昭节,王雨生.我国大陆地区近20年早产儿视网膜病变发病概况[J].中华眼科杂志, 2012,48(2):179-183.
[9] Ratra D, Akhundova L, Das MK. Retinopathy of prematurity like retinopathy in full-term infants[J]. Oman J Ophthalmol, 2017,10(3):167-172.
[10] Rothschild MI, Russ R, Brennan KA, et al. The economic model of retinopathy of prematurity(Ec ROP)screening and treatment:Mexico and the United States[J]. Am J Ophthalmol, 2016,168:110-121.
[11]张巍,尹虹,黎晓新,等.早产儿视网膜病筛查管理及成本效益分析[J].中华医院管理杂志, 2006,22(9):644-646.
[12]中国内地新生儿专业发展现状调查协作组.国内109家医院早产儿视网膜病防治现状调查[J].中华实用儿科临床杂志, 2013,28(2):86-88.
[13] Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity[J]. N Engl J Med, 2012,367(26):2515-2526.
[14] Cayabyab R, Ramanathan R. Retinopathy of prematurity:therapeutic strategies based on pathophysiology[J].Neonatology, 2016,109(4):369-376.
[15] Tunay ZO, Ozdemir O, Acar DE, et al. Maternal diabetes as an independent risk factor for retinopathy of prematurity in infants with birth weight of 1 500 g or more[J]. Am J Ophthalmol, 2016,168:201-206.
[16] Yau GS, Lee JW, Tam VT, et al. Incidence and risk factors of retinopathy of prematurity from 2 neonatal intensive care units in a Hong Kong Chinese population[J]. Asia Pac J Ophthalmol(Phila), 2016,5(3):185-191.
[17]华文娟,强丽莉,李之喆,等.单胎和多胎早产儿视网膜病变发生率比较及相关因素分析[J].中华实验眼科杂志, 2015,33(7):660-663.
[18]江静波,聂川,贺美华,等.急进性后部型早产儿视网膜病的危险因素分析[J].实用医学杂志, 2017,33(16):2697-2701.
[19]许宇. ROP的流行病学调查及Wnt信号通路相关基因研究[D].上海:上海交通大学, 2014.
[20]刘秋彤,吴艳,宋思捷,等.极低出生体重早产儿视网膜病变的相关危险因素及近期转归[J].眼科新进展, 2021,41(8):745-749.
[21] Maayan-Metzger A, Avivi S, Schushan-Eisen I, et al.Human milk versus formula feeding among preterm infants:short-term outcomes[J]. Am J Perinatol, 2012,29(2):121-126.
[22]姜海涛,李国仁.我国早产儿视网膜病变的筛查现状[J].国际眼科杂志, 2021,21(8):1386-1389.
[23]朱苾丹,李绍军,谢晓兰,等.不同医疗单位早产儿视网膜病变筛查率的分析研究[J].中国斜视与小儿眼科杂志, 2021,29(1):34-36.
[24] Azami M, Jaafari Z, Rahmati S, et al. Prevalence and risk factors of retinopathy of prematurity in Iran:a systematic review and Meta-analysis[J]. BMC Ophthalmol, 2018,18(1):83.
[25] Bas AY, Koc E, Dilmen U. Incidence and severity of retinopathy of prematurity in Turkey[J]. Br J Ophthalmol, 2015,99(10):1311-1314.
[26] Hellstrom A, Smith LE, Dammann O. Retinopathy of prematurity[J]. Lancet,2013,382(9902):1445-1457.
[27]罗慧敏.早产儿视网膜病变相关危险因素的病例对照研究[D].延安:延安大学, 2019.
[28]王小红,颉延卓,毋立新,等.早产儿视网膜病变的危险因素分析[J].临床医学研究与实践, 2020,5(28):34-36.
[29] Kamholz KL, Cole CH, Gray JE, et al. Cost-effectiveness of early treatment for retinopathy of prematurity[J]. Pediatrics, 2009,123(1):262-269.
[30] Jefferies AL. Retinopathy of prematurity:an update on screening and management[J]. Paediatr Child Health,2016,21(2):101-108.
[31] Ferrer NC, Gonzalez VI, Pueyo RV, et al. Screening program for retinopathy of prematurity in Spain[J].Arch Soc Esp Oftalmol, 2013,88(5):184-188.
[32] Arnesen L, Duran P, Silva J, et al. A multi-country,cross-sectional observational study of retinopathy of prematurity in Latin America and the Caribbean[J]. Rev Panam Salud Publica, 2016,39(6):322-329.
[33] Holmstrom GE, Hellstrom A, Jakobsson PG, et al.Swedish national register for retinopathy of prematurity(SWEDROP)and the evaluation of screening in Sweden[J]. Arch Ophthalmol, 2012,130(11):1418-1424.
[34]黎晓新.中国早产儿视网膜病变筛查指南(2014年)[J].中华眼科杂志, 2014,50(12):933-935.
[35]苏艳兰,邱小容.数字化双目间接检眼镜进行早产儿视网膜病变筛查的价值分析[J].临床医学工程,2017,24(6):735-736.
[36]肖璐璐,窦晓燕.人工智能在眼部疾病中的应用及其挑战[J].国际眼科杂志, 2020,20(7):1197-1201.
[37] Macor S, Pignatto S, Capone AJ, et al. Lens-sparing vitrectomy for stage 4A retinopathy of prematurity in infants with aggressive-posterior ROP:anatomic and functional results[J]. Eur J Ophthalmol, 2021,31(4):2020-2026.
[38]黄芬霞,李仁芳,沈华墨.早产儿视网膜病变筛查网络建设及其护理管理[J].中国实用医药, 2016,11(19):283-284.
[39]李秋平,王宗华,杨秀梅,等.以新生儿重症监护病房为基地的区域型早产儿视网膜病变治疗网络效果分析[J].中华围产医学杂志, 2019,22(9):627-632.
[40]熊永强,吕月娥,童林利,等.闽西南地区早产儿视网膜病变筛查网络建设情况研究[J].中国妇幼保健, 2014,29(33):5369-5371.
基本信息:
DOI：10.19757/j.cnki.issn1674-7763.2022.02.001
中图分类号:R774.1
引用信息:
[1]王慧冉,罗荣.早产儿视网膜病变发生及筛查现状[J].中国妇幼卫生杂志,2022,13(02):1-5.DOI:10.19757/j.cnki.issn1674-7763.2022.02.001.
2022-02-15
2022
2022-04-06
2022-05-31
2022
1
2022-03-20
2022-03-20